SARS-CoV-2 infection linked to increased benign prostatic hyperplasia (BPH) complications and medication use. Urological manifestations in COVID-19 patients emphasize the importance of awareness among clinicians.
In an observational cohort study, Hongjiang Wu and colleagues analyse data from more than 1.5 million people Hong Kong between 2002 and 2018 and compare age- and sex-specific rates of all-cause and cause-specific hospital bed-day rates in those with and without type 2 diabetes.